By Role
Subscriptions
Continuing Education
Daily Dose
Your daily dose of clinical tips and quips: Histiocytic.
Untitled Document
“Although originating from a common precursor, the benign and malignant counterparts of the histiocytic disease spectrum are vastly different in biologic behavior, recommended treatment, and prognosis. Recognizing the breed and age predilections for this spectrum of clinical diseases is paramount to identifying cases that require a diagnostic work-up.”
-Rebecca E. Risbon, VMD; Craig A. Clifford, DVM, MS, DACVIM (oncology); and Katherine Skorupski, DVM, DACVIM (oncology)
From An overview of canine histiocytic disorders
Related Videos
Related Content
